nifedipine has been researched along with Tachyarrhythmia in 45 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous diltiazem (10-300 micrograms/kg), verapamil (10-300 micrograms/kg), nifedipine (1-100 micrograms/kg) and nicardipine (1-100 micrograms/kg) inhibited the tachycardia caused by cardiac sympathetic nerve stimulation (SNS, 0." | 7.68 | Inhibitory effects of diltiazem, verapamil, nifedipine, and nicardipine on sympathetic tachycardia in decentralized hearts of anesthetized dogs. ( Kimura, T; Mukaiyama, O; Satoh, E; Satoh, S, 1990) |
| "The effects of the two calcium antagonists bepridil and nifedipine on induced ventricular tachyarrhythmias were studied by programmed electrical stimulation in 15 dogs, 4-8 days after myocardial infarction." | 7.67 | Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs. ( Aidonidis, I; Brachmann, J; Dembowsky, K; Kuebler, W; Seller, H, 1989) |
| " CR nifedipine (80 mg per day) was generally well tolerated, with the most common drug-related treatment-emergent adverse event being tachycardia (6." | 6.80 | Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension. ( Asano, K; Kajikawa, M; Kimoto, M; Matsuda, Y; Shimamoto, K, 2015) |
| "Nifedipine toxicity was characterized by vasodilatory hypotension, impaired vascular contractility, and tachycardia with terminal bradycardia." | 5.43 | Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock. ( Beuhler, MC; Kerns, WP; Murphy, CM; Nicholson, B; Quinn, ME; Shoe, T; Williams, C, 2016) |
| "002; multivariate analysis of variance), with 7 significant univariate treatment effects, all favoring COER-verapamil, being noted-pedal edema, polyuria, rapid heart beat or palpitations, hives, muscle cramps, abdominal cramps, and headaches." | 5.09 | Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. ( Anderson, RB; Hollenberg, NK; Williams, GH, 1999) |
| "Recommendations for prevention of hypertension and tachycardia during the induction of anesthesia include the use of fentanyl and antihypertensive drugs and superficial anesthesia of the throat." | 5.06 | [The effect of nifedipine and fentanyl on changes in the circulatory reaction to endotracheal intubation]. ( Fauth, U; Halmágyi, M; Heinrichs, W; Karim, S; Tzanova, I, 1989) |
| "The present evidence suggests similar efficacy between nifedipine, hydralazine and labetalol in the treatment of severe hypertension in pregnancy." | 4.98 | Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. ( Sequeira, RP; Sridharan, K, 2018) |
| " Verapamil is extremely effective in patients with supraventricular tachyarrhythmias, hypertrophic cardiomyopathy, and the various anginal syndromes, but it appears to be ineffective or possibly even deleterious in those with pulmonary hypertension, congestive heart failure of any cause, and Raynaud's phenomenon or disease." | 4.77 | Calcium antagonists in patients with cardiovascular disease. Current perspectives. ( Hillis, LD; Winniford, MD, 1985) |
| " Nifedipine and diltiazem are effective in the relief of angina, and verapamil is used in the treatment of supraventricular tachyarrhythmias." | 4.77 | Calcium channel blocking agents: physiologic basis of nursing intervention. ( Touloukian, JE, 1985) |
| " In anaesthetized Wistar rats, baroreceptor-unloading-mediated reflex activation of SNS, as indicated by tachycardia and increase of plasma catecholamines, was observed after mean arterial pressure (MAP) was decreased by 15 mmHg during 4-h administration of nifedipine, a CCB." | 3.71 | Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine. ( Wang, Z; Zhang, W, 2001) |
| "The combination of nifedipine and prazosin was more successful in preventing myocardial damage in 16 patients with hypertension than was nifedipine alone in two other patients with hypertension." | 3.68 | Management of the cardiovascular manifestations of poisoning by the Indian red scorpion (Mesobuthus tamulus). ( Bawaskar, HS; Bawaskar, PH, 1992) |
| "Intravenous diltiazem (10-300 micrograms/kg), verapamil (10-300 micrograms/kg), nifedipine (1-100 micrograms/kg) and nicardipine (1-100 micrograms/kg) inhibited the tachycardia caused by cardiac sympathetic nerve stimulation (SNS, 0." | 3.68 | Inhibitory effects of diltiazem, verapamil, nifedipine, and nicardipine on sympathetic tachycardia in decentralized hearts of anesthetized dogs. ( Kimura, T; Mukaiyama, O; Satoh, E; Satoh, S, 1990) |
| "The antihypertensive effects of nitrendipine were evaluated in 12 subjects with hypertension, one of whom could not tolerate the drug for more than 3 days; hence hemodynamics were studied in the 11 subjects who were treated for 2 wk." | 3.67 | Clinical and systemic hemodynamic effects of nitrendipine. ( Abi-Samra, F; Bravo, EL; Fouad, FM; Pedrinelli, R; Tarazi, RC; Textor, SC, 1984) |
| "The effects of three calcium antagonists (diltiazem, verapamil, and nifedipine) on reperfusion-induced arrhythmias were compared in a conscious rat preparation with coronary artery occlusion and implanted electrocardiogram limb electrodes." | 3.67 | Reperfusion-induced arrhythmias in the conscious rat: a comparative study with three calcium antagonists. ( Braimbridge, MV; Hearse, DJ; Kinoshita, K; Manning, AS; Mitani, A, 1989) |
| "The effects of the two calcium antagonists bepridil and nifedipine on induced ventricular tachyarrhythmias were studied by programmed electrical stimulation in 15 dogs, 4-8 days after myocardial infarction." | 3.67 | Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs. ( Aidonidis, I; Brachmann, J; Dembowsky, K; Kuebler, W; Seller, H, 1989) |
| " CR nifedipine (80 mg per day) was generally well tolerated, with the most common drug-related treatment-emergent adverse event being tachycardia (6." | 2.80 | Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension. ( Asano, K; Kajikawa, M; Kimoto, M; Matsuda, Y; Shimamoto, K, 2015) |
| "In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62." | 2.67 | [Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure]. ( Bechler-Lisińska, J; Cholewa, M; Górski, L; Markiewicz, K, 1990) |
| "Nifedipine toxicity was characterized by vasodilatory hypotension, impaired vascular contractility, and tachycardia with terminal bradycardia." | 1.43 | Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock. ( Beuhler, MC; Kerns, WP; Murphy, CM; Nicholson, B; Quinn, ME; Shoe, T; Williams, C, 2016) |
| "Nifedipine tocolysis was associated with hemodynamic changes in non-hypertensive women." | 1.42 | Hemodynamic effects of nifedipine tocolysis. ( Burlingame, J; Kaneshiro, B; Yamasato, K, 2015) |
| "1 mg/kg) occurred during an 8-week repeated daily dosing to RHD and plasma renin activity, and aldosterone levels were not elevated during this period." | 1.28 | Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state. ( Aoki, K; Fukunari, A; Katoh, A; Nakajima, T; Setoguchi, M; Shinagawa, K; Shinohara, T; Tahara, T; Yamanaka, T; Yaoka, O, 1992) |
| "Twenty-six patients had no ventricular arrhythmias in 633 ischemic attacks; 16 patients had ventricular arrhythmias in 116/586 ischemic attacks." | 1.27 | [Characterization and therapy of ventricular arrhythmias due to transient myocardial ischemic attacks in variant angina]. ( Dini, P; Prati, PL; Rocca, P; Turitto, G; Vicari, M; Zanchi, E, 1984) |
| "Confusion and sleep disorders constitute 8 cases." | 1.27 | Nifedipine--a survey of adverse effects. Four years' reporting in Sweden. ( Myrhed, M; Wiholm, BE, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (60.00) | 18.7374 |
| 1990's | 9 (20.00) | 18.2507 |
| 2000's | 3 (6.67) | 29.6817 |
| 2010's | 6 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G | 1 |
| Wang, J | 1 |
| Liao, P | 1 |
| Bartels, P | 1 |
| Zhang, H | 1 |
| Yu, D | 1 |
| Liang, MC | 1 |
| Poh, KK | 1 |
| Yu, CY | 1 |
| Jiang, F | 1 |
| Yong, TF | 1 |
| Wong, YP | 1 |
| Hu, Z | 1 |
| Huang, H | 1 |
| Zhang, G | 1 |
| Galupo, MJ | 1 |
| Bian, JS | 1 |
| Ponniah, S | 1 |
| Trasti, SL | 1 |
| See, K | 1 |
| Foo, R | 1 |
| Hoppe, UC | 1 |
| Herzig, S | 1 |
| Soong, TW | 1 |
| Sridharan, K | 1 |
| Sequeira, RP | 1 |
| Yamasato, K | 1 |
| Burlingame, J | 1 |
| Kaneshiro, B | 1 |
| Shimamoto, K | 1 |
| Kimoto, M | 1 |
| Matsuda, Y | 1 |
| Asano, K | 1 |
| Kajikawa, M | 1 |
| Rezk, M | 1 |
| Sayyed, T | 1 |
| Masood, A | 1 |
| Dawood, R | 1 |
| Murphy, CM | 1 |
| Williams, C | 1 |
| Quinn, ME | 1 |
| Nicholson, B | 1 |
| Shoe, T | 1 |
| Beuhler, MC | 1 |
| Kerns, WP | 1 |
| Fryer, RM | 1 |
| Preusser, LC | 1 |
| Calzadilla, SV | 1 |
| Hu, Y | 1 |
| Xu, H | 1 |
| Marsh, KC | 1 |
| Cox, BF | 1 |
| Lin, CT | 1 |
| Gopalakrishnan, M | 1 |
| Reinhart, GA | 1 |
| Gould, S | 1 |
| Westwood, FR | 1 |
| Curwen, JO | 1 |
| Ashton, SE | 1 |
| Roberts, DW | 1 |
| Lovick, SC | 1 |
| Ryan, AJ | 1 |
| Karlsberg, RP | 1 |
| Meyer, J | 1 |
| Zipes, DP | 1 |
| Gilmour, RF | 1 |
| Johnston, WE | 1 |
| Lowenstein, E | 1 |
| Maclean, D | 1 |
| Feely, J | 1 |
| Hope, RR | 1 |
| Lazzara, R | 1 |
| Turitto, G | 1 |
| Dini, P | 1 |
| Rocca, P | 1 |
| Vicari, M | 1 |
| Zanchi, E | 1 |
| Prati, PL | 1 |
| Fouad, FM | 1 |
| Pedrinelli, R | 1 |
| Bravo, EL | 1 |
| Abi-Samra, F | 1 |
| Textor, SC | 1 |
| Tarazi, RC | 1 |
| Zaret, GM | 1 |
| Senges, J | 1 |
| Rizos, I | 1 |
| Brachmann, J | 2 |
| Anders, G | 1 |
| Jauernig, R | 1 |
| Hamman, HD | 1 |
| Kübler, W | 1 |
| Grayson, HA | 1 |
| Kennedy, JD | 1 |
| Sheehan, FH | 1 |
| Epstein, SE | 1 |
| Resnekov, L | 1 |
| Krikler, DM | 1 |
| Rowland, E | 1 |
| Gutiérrez, L | 1 |
| Valle, V | 1 |
| Cinca, J | 1 |
| Ríus, J | 1 |
| Motomura, S | 1 |
| Taira, N | 1 |
| Lorell, BH | 1 |
| Turi, Z | 1 |
| Grossman, W | 1 |
| Ribeiro, LG | 1 |
| DeBauche, TL | 1 |
| Brandon, TA | 1 |
| Maroko, PR | 1 |
| Miller, RR | 1 |
| Bawaskar, HS | 2 |
| Bawaskar, PH | 2 |
| Sirtori, CR | 1 |
| Franceschini, G | 1 |
| Gurtu, S | 1 |
| Mukerjee, D | 1 |
| Shukla, S | 1 |
| Azaz-Livshits, TL | 1 |
| Danenberg, HD | 1 |
| Anderson, RB | 1 |
| Hollenberg, NK | 1 |
| Williams, GH | 1 |
| Zhang, W | 1 |
| Wang, Z | 1 |
| Refsum, H | 1 |
| Glomstein, A | 1 |
| Landmark, K | 1 |
| Nakajima, T | 1 |
| Shinohara, T | 1 |
| Yaoka, O | 1 |
| Fukunari, A | 1 |
| Shinagawa, K | 1 |
| Aoki, K | 1 |
| Katoh, A | 1 |
| Yamanaka, T | 1 |
| Setoguchi, M | 1 |
| Tahara, T | 1 |
| Satoh, E | 1 |
| Mukaiyama, O | 1 |
| Kimura, T | 1 |
| Satoh, S | 1 |
| Bechler-Lisińska, J | 1 |
| Cholewa, M | 1 |
| Górski, L | 1 |
| Markiewicz, K | 1 |
| Heinrichs, W | 1 |
| Fauth, U | 1 |
| Tzanova, I | 1 |
| Karim, S | 1 |
| Halmágyi, M | 1 |
| Kinoshita, K | 1 |
| Mitani, A | 1 |
| Hearse, DJ | 1 |
| Braimbridge, MV | 1 |
| Manning, AS | 1 |
| Aidonidis, I | 1 |
| Dembowsky, K | 1 |
| Seller, H | 1 |
| Kuebler, W | 1 |
| Rousseau, MF | 1 |
| Hanet, C | 1 |
| Pardonge-Lavenne, E | 1 |
| Van den Berghe, G | 1 |
| Van Hoof, F | 1 |
| Pouleur, H | 1 |
| Myrhed, M | 1 |
| Wiholm, BE | 1 |
| Winniford, MD | 1 |
| Hillis, LD | 1 |
| Touloukian, JE | 1 |
| Sia, ST | 1 |
| MacDonald, PS | 1 |
| Triester, B | 1 |
| Oliver, LE | 1 |
| Horowitz, JD | 1 |
| Goble, AJ | 1 |
7 reviews available for nifedipine and Tachyarrhythmia
| Article | Year |
|---|---|
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hy | 2018 |
[Use of calcium antagonists in the therapy of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Coronary Disease; Diltiazem; Drug Therapy, Co | 1983 |
Calcium antagonists and their potential role in the prevention of sudden coronary death.
Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Calcium Chan | 1982 |
Calcium channel blocking drugs.
Topics: Anesthesia; Angina Pectoris; Animals; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophi | 1983 |
The clinical uses of calcium antagonists.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel B | 1982 |
Calcium antagonists in patients with cardiovascular disease. Current perspectives.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Benzazepines; Cardio | 1985 |
Calcium channel blocking agents: physiologic basis of nursing intervention.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrioventricular Node; Calcium; Calcium Channel Blockers; | 1985 |
6 trials available for nifedipine and Tachyarrhythmia
| Article | Year |
|---|---|
Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension.
Topics: Aged; Asian People; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Double-Bl | 2015 |
RETRACTED: Nicorandil vs nifedipine for the treatment of preterm labour: a randomized clinical trial.
Topics: Adolescent; Adult; Double-Blind Method; Female; Fetal Diseases; Headache; Humans; Nicorandil; Nifedi | 2015 |
Vasodilators: scorpion envenoming and the heart (an Indian experience).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Bradycardia; Cardiovascular Diseases; Child; Ch | 1994 |
Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Constipation; Dou | 1999 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output | 1990 |
[The effect of nifedipine and fentanyl on changes in the circulatory reaction to endotracheal intubation].
Topics: Adult; Blood Pressure; Epinephrine; Female; Fentanyl; Heart Rate; Humans; Hypertension; Intubation, | 1989 |
32 other studies available for nifedipine and Tachyarrhythmia
| Article | Year |
|---|---|
Exclusion of alternative exon 33 of Ca
Topics: Action Potentials; Alternative Splicing; Animals; Calcium Channel Blockers; Calcium Channels, L-Type | 2017 |
Hemodynamic effects of nifedipine tocolysis.
Topics: Adolescent; Adult; Blood Pressure; Female; Heart Rate; Humans; Hypotension; Nifedipine; Pregnancy; R | 2015 |
Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock.
Topics: Animals; Blood Glucose; Blood Pressure; Bradycardia; Calcium Channel Blockers; Dihydropyridines; Dis | 2016 |
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine.
Topics: Adenosine Triphosphate; Amides; Animals; Benzophenones; Blood Pressure; Cyclic S-Oxides; Cyclobutane | 2004 |
Effect of pretreatment with atenolol and nifedipine on ZD6126-induced cardiac toxicity in rats.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Antineoplasti | 2007 |
Welcome--the calcium channel blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blocker | 1981 |
Calcium antagonists, nitrates, and new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Isosorbide Dinitrate; Lidoflazine; | 1983 |
[Characterization and therapy of ventricular arrhythmias due to transient myocardial ischemic attacks in variant angina].
Topics: Adult; Aged; Angina Pectoris, Variant; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; | 1984 |
Clinical and systemic hemodynamic effects of nitrendipine.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Volume; Cardiac Output; Dose-Response Re | 1984 |
Therapeutic uses of calcium channel blockers.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiovascular System; Diltiazem; | 1983 |
Effect of nifedipine and AQ-A 39 on the sinoatrial and atrioventricular nodes of the rabbit and their antiarrhythmic action on atrioventricular nodal reentrant tachycardia.
Topics: Action Potentials; Animals; Atrioventricular Node; Cardiovascular Agents; Heart Conduction System; I | 1983 |
Nifedipine and torsades de pointes.
Topics: Humans; Nifedipine; Pyridines; Tachycardia | 1983 |
Effects of calcium channel blocking agents on reperfusion arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dogs; Female; He | 1982 |
Calcium ion blocking drugs.
Topics: Administration, Oral; Bradycardia; Calcium Channel Blockers; Diltiazem; Dizziness; Headache; Heart D | 1982 |
Torsade de pointes and nifedipine.
Topics: Humans; Nifedipine; Pyridines; Tachycardia | 1982 |
[Electrophysiologic effects of nifedipine in humans. Comparison with verapamil].
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Female; Heart; Heart Conduction System; Humans; Male | 1982 |
Differential effects of organic slow inward current inhibitors, verapamil and nifedipine, on rate of atrioventricular rhythm and supraventricular tachycardia in the canine isolated, blood-perfused AV node preparation.
Topics: Animals; Atrioventricular Node; Dogs; Female; Heart Conduction System; Heart Rate; Male; Nifedipine; | 1981 |
Modification of left ventricular response to pacing tachycardia in nifedipine in patients with coronary artery disease.
Topics: Calcium Channel Blockers; Cineangiography; Coronary Disease; Heart Ventricles; Hemodynamics; Humans; | 1981 |
Comparative effects of verapamil and nifedipine on reactive hyperemia and ventricular arrhythmias during coronary artery reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Femal | 1980 |
[Pharmacological control of heart rate].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Animals; Benzazepines; Blood Pressure; | 1994 |
Evidence for a role of inhibition of sympathetic neurotransmission in the cardiovascular effects of intravenously administered verapamil.
Topics: Animals; Blood Pressure; Cats; Diltiazem; Epinephrine; Female; Heart; Heart Rate; Injections, Intrav | 1995 |
Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Drug Interactions; Drug | 1997 |
Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium | 2001 |
The effect of nifedipine on the isolated rat heart.
Topics: Animals; Blood Pressure; Calcium; Coronary Circulation; Female; Heart; Heart Rate; Myocardial Contra | 1976 |
Management of the cardiovascular manifestations of poisoning by the Indian red scorpion (Mesobuthus tamulus).
Topics: Adult; Aged; Animals; Cardiovascular Diseases; Child; Child, Preschool; Drug Therapy, Combination; F | 1992 |
Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Benzopyrans; Blood Pressure; Cromakalim; Dog | 1992 |
Inhibitory effects of diltiazem, verapamil, nifedipine, and nicardipine on sympathetic tachycardia in decentralized hearts of anesthetized dogs.
Topics: Analysis of Variance; Animals; Blood Pressure; Coronary Circulation; Diltiazem; Dogs; Dose-Response | 1990 |
Reperfusion-induced arrhythmias in the conscious rat: a comparative study with three calcium antagonists.
Topics: Animals; Arrhythmias, Cardiac; Consciousness; Coronary Disease; Diltiazem; Electrocardiography; Hear | 1989 |
Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs.
Topics: Animals; Bepridil; Calcium Channel Blockers; Cardiac Pacing, Artificial; Consciousness; Dogs; Electr | 1989 |
Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Pacing, Artificial; Chronic Disease; Exercise | 1986 |
Nifedipine--a survey of adverse effects. Four years' reporting in Sweden.
Topics: Adult; Aged; Angina Pectoris; Confusion; Erythema; Female; Headache; Heart Failure; Humans; Male; Mi | 1986 |
Aggravation of myocardial ischaemia by nifedipine.
Topics: Coronary Disease; Female; Humans; Hypotension; Male; Middle Aged; Myocardial Infarction; Nifedipine; | 1985 |